These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3143298)

  • 1. Stimulation protocols for patients with "atypical response".
    Muasher SJ
    Ann N Y Acad Sci; 1988; 541():82-95. PubMed ID: 3143298
    [No Abstract]   [Full Text] [Related]  

  • 2. Can GnRH agonists act directly on the ovary and contribute to cyst formation?
    Mehta RH; Anand Kumar TC
    Hum Reprod; 2000 Mar; 15(3):505-7. PubMed ID: 10686187
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction.
    Westergaard LG; Laursen SB; Andersen CY
    Hum Reprod; 2000 May; 15(5):1003-8. PubMed ID: 10783342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
    Lin WQ; Yang HY; Lin JJ; Chen X; Ye BL
    Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells.
    Minaretzis D; Alper MM; Oskowitz SP; Lobel SM; Mortola JF; Pavlou SN
    Am J Obstet Gynecol; 1995 May; 172(5):1518-25. PubMed ID: 7755066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does day-3 LH/FSH ratio influence in vitro fertilization outcome in PCOS patients undergoing controlled ovarian hyperstimulation with different GnRH-analogue?
    Orvieto R; Meltcer S; Liberty G; Rabinson J; Anteby EY; Nahum R
    Gynecol Endocrinol; 2012 Jun; 28(6):422-4. PubMed ID: 22578028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Regulation principles of female gonadal function. Experimental observations and clinical significance].
    Czygan PJ
    Fortschr Geburtshilfe Gynakol; 1974; 52():121-98. PubMed ID: 4618236
    [No Abstract]   [Full Text] [Related]  

  • 8. Foundations of the clinical use of LHRH: early studies with the porcine hypothalamic hormone.
    Kastin AJ; Zadina JE; Schally AV
    Mater Med Pol; 1980; 12(1-2):33-6. PubMed ID: 6799707
    [No Abstract]   [Full Text] [Related]  

  • 9. Predictive factors for ovarian response in a corifollitropin alfa/GnRH antagonist protocol for controlled ovarian stimulation in IVF/ICSI cycles.
    Oehninger S; Nelson SM; Verweij P; Stegmann BJ
    Reprod Biol Endocrinol; 2015 Oct; 13():117. PubMed ID: 26520396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of serum follicle stimulating hormone to luteinizing hormone ratio during buserelin acetate-induced pituitary desensitization on ovarian response to exogenous gonadotrophins in an in-vitro fertilization and embryo transfer programme.
    Yamashita T; Ishimaru T; Fujishita A; Kawano M; Yamabe T
    Hum Reprod; 1996 Aug; 11(8):1615-9. PubMed ID: 8921103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics of pituitary down-regulation and ovarian response to controlled stimulation in in vitro fertilization cycles.
    Mohamed KA; Davies WA; Lashen H
    Fertil Steril; 2007 Feb; 87(2):433-5. PubMed ID: 17094983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
    Hohmann FP; Macklon NS; Fauser BC
    J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical use of LH-RH analogs. 1. Ovulation induction. Hormonal profiles of various protocols].
    Zorn JR; Cedard L; Janssens Y
    J Gynecol Obstet Biol Reprod (Paris); 1990; 19(5):588-92. PubMed ID: 2120320
    [No Abstract]   [Full Text] [Related]  

  • 14. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI; Winter JS; Faiman C
    Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders.
    Filicori M; Flamigni C; Meriggiola MC; Ferrari P; Michelacci L; Campaniello E; Valdiserri A; Cognigni G
    J Clin Endocrinol Metab; 1991 May; 72(5):965-72. PubMed ID: 1902487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microdose gonadotropin-releasing hormone agonist in the absence of exogenous gonadotropins is not sufficient to induce multiple follicle development.
    Chung K; Fogle R; Bendikson K; Christenson K; Paulson R
    Fertil Steril; 2011 Jan; 95(1):317-9. PubMed ID: 20813363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal serum pituitary hormone levels and outcome of in vitro fertilization utilizing a flare nasal gonadotropin releasing hormone agonist and fixed low-dose follicle-stimulating hormone/human menopausal gonadotropin regimen.
    Chan YF; Ho PC; So WW; Yeung WS
    J Assist Reprod Genet; 1993 May; 10(4):251-4. PubMed ID: 8130428
    [No Abstract]   [Full Text] [Related]  

  • 18. Results of the use of a pure urinary FSH stimulation regime in patients unsuccessfully treated with hMG in an in vitro fertilization program.
    Grillo M; Buck S; Freys I; Mettler L
    Gynecol Obstet Invest; 1989; 28(4):169-73. PubMed ID: 2533578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of a gonadotropin releasing hormone (GnRH) antagonist and exogenous gonadotropins to unstimulated in vitro fertilization (IVF) cycles: physiologic observations and preliminary experience.
    Paulson RJ; Sauer MV; Lobo RA
    J Assist Reprod Genet; 1994 Jan; 11(1):28-32. PubMed ID: 7949832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of buserelin on the hormonal states in PCOD.
    Willemsen WN; Franssen AM; Rolland R; Vemer HM
    Prog Clin Biol Res; 1986; 225():377-89. PubMed ID: 3097673
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.